Beverley is national leader of BLG's Intellectual Property Litigation Group. She practises in all areas of intellectual property litigation, with a focus on complex patent and trademark disputes. Beverley also has significant experience with actions brought under the Patented Medicines (Notice of Compliance) Regulations.
Beverley represents clients in a multitude of sectors including life sciences, technology, gaming and mining for patent litigation. She is also interested in the intersection of IP with artificial intelligence and the metaverse as well as other emerging technologies.
Beverley regularly provides strategic advice to clients in all sectors on patent portfolio management and trade secrets. In addition, Beverley advises on patentability, validity and freedom-to-operate issues, and aids in the prosecution of patent applications in Canada.
Having worked with life sciences and biotechnology companies throughout her career, Beverley uses that experience to provide strategic advice on navigating Canada's IP regulatory issues including listing patents on the Patent Register, reporting patents to the Patented Medicines Prices Review Board, Certificates of Supplementary Protection and the Register of Innovative Drugs as it relates to data protection. In addition, Beverley advises on Access to Information requests, in particular those made to Health Canada by pharmaceutical clients.
Beverley consulted on the implementation and application of the intellectual property provisions of the Comprehensive Economic and Trade Agreement (CETA) between Canada and the European Union and has advised on the United States-Mexico-Canada Agreement (USMCA).
Beverley has advocated before the Federal Court and Federal Court of Appeal, the Patent Appeal Board and the Patented Medicine Prices Review Board.
Throughout her career, Beverley has been very active in the legal profession. She is one of the founding Co-chairs of the Eastern Canada Chapter of ChIPs. Beverley is the current chair of the CBA IP Section's Court Practice Committee. She sits on the Steering Committee for DRI's IP Litigation Committee and is one of the co-vice chairs of IPOwner's Pharmaceutical and Biotechnology Issues Committee. In addition, she is a regular speaker and writer on IP issues, and serves on the BLG's Thought Leadership Committee. In addition, she is both a formal and informal mentor to students and associates at BLG.